MARKET

AYTU

AYTU

Aytu Biopharma Inc
NASDAQ
2.240
+0.110
+5.16%
After Hours: 2.240 0 0.00% 16:10 12/04 EST
OPEN
2.140
PREV CLOSE
2.130
HIGH
2.240
LOW
2.114
VOLUME
51.62K
TURNOVER
--
52 WEEK HIGH
2.820
52 WEEK LOW
0.9500
MARKET CAP
22.82M
P/E (TTM)
-0.9998
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AYTU last week (1124-1128)?
Weekly Report · 4d ago
Aytu BioPharma Presents at Noble Capital Markets Emerging Growth Equity Conference
Reuters · 11/24 21:05
Weekly Report: what happened at AYTU last week (1117-1121)?
Weekly Report · 11/24 09:32
Nutex Health Soars 21% After Hours On Revenue Surge; Biotech Peers Join Tuesday Gainers
NASDAQ · 11/19 04:44
Aytu Biopharma Unveils Strategic Focus on CNS Therapeutics and EXXUA Launch in Latest Corporate Presentation
Reuters · 11/18 17:09
Weekly Report: what happened at AYTU last week (1110-1114)?
Weekly Report · 11/17 09:33
Aytu BioScience Earnings Call Highlights Growth and Challenges
TipRanks · 11/16 00:08
Aytu BioScience: Strong Financial Performance and Strategic Initiatives Drive Buy Rating
TipRanks · 11/15 12:35
More
About AYTU
Aytu BioPharma, Inc. is a pharmaceutical company focused on advancing medicines for complex central nervous system (CNS) diseases. Its business is focused on the launch of EXXUA and its prescription pharmaceutical products sold primarily through third-party wholesalers and pharmacies and which primarily consists of two product portfolios. Its Attention Deficit Hyperactivity Disorder (ADHD) portfolio consists of Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) , Cotempla XR-ODT, and METADATE CD, which are CNS stimulants indicated for the treatment of ADHD in patients. Its Pediatric portfolio consists of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine indicated to treat various allergic conditions including seasonal and perennial allergic rhinitis, vasomotor rhinitis, Poly-Vi-Flor, and Tri-Vi-Flor. EXXUA is indicated to treat depressive disorder (MDD) in adults.

Webull offers Aytu Biopharma Inc stock information, including NASDAQ: AYTU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AYTU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AYTU stock methods without spending real money on the virtual paper trading platform.